These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 2881837
1. (+/-)-1-[[2-(3,4-Dimethoxphenyl)ethyl]amino]-3-(3-methylphenoxy)-2- propanol hydrochloride (bevantolol, NC-1400) as a beta 1-selective adrenoceptor blocker with alpha 1-adrenoceptor blocking activity. Takayanagi I, Kizawa Y, Iwasaki S, Nakagoshi A. Gen Pharmacol; 1987; 18(1):87-9. PubMed ID: 2881837 [Abstract] [Full Text] [Related]
2. Alpha 1-adrenoceptor blocking activities of bevantolol hydrochloride(NC-1400) and labetalol in rat isolated thoracic aorta--do they distinguish between subtypes? Shiraishi K, Moriya M, Miyake N, Takayanagi I. Gen Pharmacol; 1992 Sep; 23(5):843-5. PubMed ID: 1358746 [Abstract] [Full Text] [Related]
3. Actions of 4-(2-hydroxy-3-[(1-methyl-3-phenylpropyl)amino]propoxy) benzeneacetamide (KF4317) and labetalol on alpha- and beta-adrenoceptors. Takayanagi I, Koike K, Konno F, Hiruta T, Kusunoki M, Sato T, Toyoda J, Kizawa Y. Gen Pharmacol; 1986 Sep; 17(6):651-3. PubMed ID: 3028902 [Abstract] [Full Text] [Related]
4. The alpha- and beta-adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anaesthetized dogs and in isolated tissues. Brittain RT, Drew GM, Levy GP. Br J Pharmacol; 1982 Sep; 77(1):105-14. PubMed ID: 6127131 [Abstract] [Full Text] [Related]
5. Pharmacology of 4-(2-hydroxy-3-[(1-methyl-3-phenylpropyl)-amino]propoxy)benzeneacetamide (KF-4317). Kubo K, Nakamura J, Karasawa A, Shuto K, Nakamizo N. Arzneimittelforschung; 1983 Sep; 33(7):926-31. PubMed ID: 6138045 [Abstract] [Full Text] [Related]
6. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent. Miyagishi A, Nakahara H, Hara Y. Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068 [Abstract] [Full Text] [Related]
7. Beta 1- and beta 2-adrenoceptor antagonist activities of ICI-215001, a putative beta 3-adrenoceptor agonist. Tesfamariam B, Allen GT. Br J Pharmacol; 1994 May; 112(1):55-8. PubMed ID: 7913381 [Abstract] [Full Text] [Related]
8. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug. Brittain RT, Levy GP. Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948 [Abstract] [Full Text] [Related]
9. Adrenoceptor-blocking activity and cardiohemodynamic effects of carvedilol in animals. Kawada T, Ishibashi T, Nakazawa M, Satoh S, Imai S. J Cardiovasc Pharmacol; 1990 Jul; 16(1):147-53. PubMed ID: 1696657 [Abstract] [Full Text] [Related]
10. Selectivity of bevantolol hydrochloride towards alpha- and beta-adrenoceptor subtypes in rat cerebral cortex. Takita M, Kigoshi S, Muramatsu I. Jpn J Pharmacol; 1992 Feb; 58(2):193-6. PubMed ID: 1354761 [Abstract] [Full Text] [Related]
11. Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol. Horinouchi T, Morishima S, Tanaka T, Suzuki F, Tanaka Y, Koike K, Miwa S, Muramatsu I. Life Sci; 2007 Jul 12; 81(5):399-404. PubMed ID: 17628611 [Abstract] [Full Text] [Related]
12. Demonstration of the beta 2-adrenoceptor intrinsic efficacy of AY-28,925 using the PGF2 alpha-contracted guinea-pig trachea. Heaslip RJ, Giesa FR, Rimele TJ, Grimes D. Eur J Pharmacol; 1987 Jun 04; 137(2-3):179-84. PubMed ID: 2886349 [Abstract] [Full Text] [Related]
13. Comparison of the beta-adrenoceptor affinity and selectivity of cetamolol, atenolol, betaxolol, and ICI-118,551. Rimele TJ, Henry DE, Giesa FR, Buckley SK, Geiger G, Heaslip RJ, Lee DK, Grimes D. J Cardiovasc Pharmacol; 1988 Aug 04; 12(2):208-17. PubMed ID: 2459552 [Abstract] [Full Text] [Related]
14. Adrenoceptor mechanisms in the cardiovascular effects of cocaine in conscious squirrel monkeys. Schindler CW, Tella SR, Goldberg SR. Life Sci; 1992 Aug 04; 51(9):653-60. PubMed ID: 1354322 [Abstract] [Full Text] [Related]
15. beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells. Haynes JM. Eur J Pharmacol; 2007 Sep 10; 570(1-3):18-26. PubMed ID: 17617401 [Abstract] [Full Text] [Related]
16. The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers. Riva E, Mennini T, Latini R. Br J Pharmacol; 1991 Dec 10; 104(4):823-8. PubMed ID: 1687367 [Abstract] [Full Text] [Related]
17. An homogeneous population of beta 1-adrenoceptors subserves inhibitory responses in guinea-pig ileal preparations. Mian MA, Malta E, Raper C. J Pharm Pharmacol; 1984 Oct 10; 36(10):698-9. PubMed ID: 6150092 [Abstract] [Full Text] [Related]
18. Eugenodilol: a third-generation beta-adrenoceptor blocker, derived from eugenol, with alpha-adrenoceptor blocking and beta2-adrenoceptor agonist-associated vasorelaxant activities. Huang YC, Wu BN, Lin YT, Chen SJ, Chiu CC, Cheng CJ, Chen IJ. J Cardiovasc Pharmacol; 1999 Jul 10; 34(1):10-20. PubMed ID: 10413061 [Abstract] [Full Text] [Related]
19. [Alpha- and beta-adrenoceptor blocking actions of labetalol and effects on the myocardial function, coronary circulation and myocardial energy metabolism thereof (author's transl)]. Katano Y, Takeda K, Nakagawa Y, Hashimoto T, Nakazawa M, Tsukada T, Otorii T, Imai S. Nihon Yakurigaku Zasshi; 1978 Oct 10; 74(7):819-32. PubMed ID: 33880 [Abstract] [Full Text] [Related]
20. Comparative effects of beta-, alpha- and combined beta- plus alpha-adrenoceptor blocking agents in stress-induced increase in arterial blood pressure. Pandhi P, Sharma PL. Int J Clin Pharmacol Ther Toxicol; 1987 Jun 10; 25(6):297-300. PubMed ID: 2887519 [Abstract] [Full Text] [Related] Page: [Next] [New Search]